Cargando…

Association of time in range with hemoglobin A1c, glycated albumin and 1,5‐anhydro‐d‐glucitol

AIMS/INTRODUCTION: Hemoglobin A1c (HbA1c), glycated albumin (GA) and 1,5‐anhydro‐d‐glucitol (1,5‐AG) are used as indicators of glycemic control, whereas continuous glucose monitoring (CGM) is used to assess daily glucose profiles. The aim of this study was to investigate the relationships between CG...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ohigashi, Mana, Osugi, Keiko, Kusunoki, Yoshiki, Washio, Kahori, Matsutani, Satoshi, Tsunoda, Taku, Matsuo, Toshihiro, Konishi, Kosuke, Katsuno, Tomoyuki, Namba, Mitsuyoshi, Koyama, Hidenori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8169363/ https://www.ncbi.nlm.nih.gov/pubmed/33058513 http://dx.doi.org/10.1111/jdi.13437

Ejemplares similares

Relationships between time in range, glycemic variability including hypoglycemia and types of diabetes therapy in Japanese patients with type 2 diabetes mellitus: Hyogo Diabetes Hypoglycemia Cognition Complications study
por: Kuroda, Norihiro, et al.
Publicado: (2020)

The Application of Plasma 1,5-Anhydro-D-glucitol for Monitoring Type 2 Diabetic Patients
por: Dworacka, Marzena, et al.
Publicado: (2005)

Profile of saxagliptin in the treatment of type 2 diabetes: focus on Japanese patients
por: Konya, Hiroyuki, et al.
Publicado: (2014)

Low levels of 1,5-anhydro-D-glucitol are associated with vascular endothelial dysfunction in type 2 diabetes
por: Torimoto, Keiichi, et al.
Publicado: (2014)

Association of Hemoglobin A1c, 1,5-Anhydro-d-Glucitol and Glycated Albumin with Oxidative Stress in Type 2 Diabetes Mellitus Patients: A Cross-Sectional Study
por: Kohata, Yo, et al.
Publicado: (2020)

Significance of Glycemic Variability in Diabetes Mellitus
por: Kusunoki, Yoshiki, et al.
Publicado: (2021)

1,5-Anhydro-D-Glucitol Could Reflect Hypoglycemia Risk in Patients with Type 2 Diabetes Receiving Insulin Therapy
por: Kim, Min Kyeong, et al.
Publicado: (2016)

Impact of serum 1,5-anhydro-d-glucitol level on the prediction of severe coronary artery calcification: an intravascular ultrasound study
por: Wada, Hideki, et al.
Publicado: (2019)

Xanthine oxidoreductase activity is correlated with hepatic steatosis
por: Yagi, Chisako, et al.
Publicado: (2022)

Excretion rates of 1,5-anhydro-D-glucitol, uric acid and microalbuminuria as glycemic control indexes in patients with type 2 diabetes
por: Ma, Cong, et al.
Publicado: (2017)

Single Amino Acid Mutation of Pyranose 2-Oxidase Results in Increased Specificity for Diabetes Biomarker 1,5-Anhydro-D-Glucitol
por: Fujii, Takahiro, et al.
Publicado: (2020)

A case of type 1 diabetes mellitus with which localized insulin allergy was markedly alleviated by switching to insulin glulisine
por: Watanabe, Kahori, et al.
Publicado: (2016)

Development of Novel Low-Molecular-Mass Oil-gelling Agents: Synthesis and Physical Properties of 1,5-Anhydro-D-glucitol and 1,5-Anhydro-D-mannitol Protected with Saturated Linear Fatty Acids
por: Kajiki, Takahito, et al.
Publicado: (2019)

Association between low‐carbohydrate diets and continuous glucose monitoring‐derived time in ranges
por: Osugi, Keiko, et al.
Publicado: (2023)

Plasma 1,5-anhydro-d-glucitol is associated with peripheral nerve function and diabetic peripheral neuropathy in patients with type 2 diabetes and mild-to-moderate hyperglycemia
por: Xu, Feng, et al.
Publicado: (2022)

High-temperature solvent-free synthesis of low-molecular-weight organogelators consisting of starch-derived 1,5-anhydro-d-glucitol coupled with fatty acids
por: Komba, Shiro, et al.
Publicado: (2023)

The clinical impact of serum 1,5-anhydro-D-glucitol levels on coronary artery calcification and adverse outcomes assessed by coronary optical coherence tomography in diabetic patients
por: Teng, Hsin-I, et al.
Publicado: (2022)

Very Short-Term Effects of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin on the Secretion of Insulin, Glucagon, and Incretin Hormones in Japanese Patients with Type 2 Diabetes Mellitus: Analysis of Meal Tolerance Test Data
por: Murai, Kazuki, et al.
Publicado: (2014)

Effects of the naturally‐occurring disaccharides, palatinose and sucrose, on incretin secretion in healthy non‐obese subjects
por: Maeda, Aya, et al.
Publicado: (2013)

Postabsorptive hyperglucagonemia in patients with type 2 diabetes mellitus analyzed with a novel enzyme‐linked immunosorbent assay
por: Matsuo, Toshihiro, et al.
Publicado: (2015)

Clinical impact of (11)C-Pittsburgh compound-B positron emission tomography in addition to magnetic resonance imaging and single-photon emission computed tomography on diagnosis of mild cognitive impairment to Alzheimer's disease
por: Kitajima, Kazuhiro, et al.
Publicado: (2021)

Incretin responses to oral glucose load in Japanese non-obese healthy subjects
por: Nagai, Etsuko, et al.
Publicado: (2011)

Chemoenzymatic Synthesis of D-Glucitol-Based Non-Ionic Amphiphilic Architectures as Nanocarriers
por: Manchanda, Priyanka, et al.
Publicado: (2020)

Medium-Term Effects of Insulin Degludec on Patients with Type 1 Diabetes Mellitus
por: Nakae, Rie, et al.
Publicado: (2014)

Estimation of HbA1c response to sitagliptin by change in glycated albumin level for 2 weeks
por: Hamaguchi, Tomoya, et al.
Publicado: (2011)

Effects of combination therapy with mitiglinide and voglibose on postprandial plasma glucose in patients with type 2 diabetes mellitus
por: Konya, Hiroyuki, et al.
Publicado: (2013)

Coupling Reactions of Anhydro-Aldose Tosylhydrazones with Boronic Acids
por: Kaszás, Tímea, et al.
Publicado: (2022)

Immunological evidence for in vivo production of novel advanced glycation end-products from 1,5-anhydro-D-fructose, a glycogen metabolite
por: Sakasai-Sakai, Akiko, et al.
Publicado: (2019)

Tritium-Labeled Compounds VIII. Confirmation of the Position of the Tritium in d-Glucose-6-t and d-Glucitol-5-t
por: Sniegoski, Lorna T., et al.
Publicado: (1962)

Medium-Term Effect of Add-On Therapy with the DPP-4 Inhibitor, Sitagliptin, in Insulin-Treated Japanese Patients with Type 2 Diabetes Mellitus
por: Katsuno, Tomoyuki, et al.
Publicado: (2016)

Effects of Switching from Insulin Glargine or Detemir to Insulin Degludec in Patients with Type 1 Diabetes Mellitus
por: Kusunoki, Yoshiki, et al.
Publicado: (2013)

2,6-Anhydro-1,3-di-O-benzyl-d-mannitol
por: de Siqueira, Edmilson Clarindo, et al.
Publicado: (2011)

Catalytic process of anhydro-N-acetylmuramic acid kinase from Pseudomonas aeruginosa
por: El-Araby, Amr M., et al.
Publicado: (2023)

Sleep quality, autonomic dysfunction and renal function in diabetic patients with pre-CKD phase
por: Kadoya, Manabu, et al.
Publicado: (2021)

An efficient synthesis of 1,6-anhydro-N-acetylmuramic acid from N-acetylglucosamine
por: Calvert, Matthew B, et al.
Publicado: (2017)

Membrane-enclosed multienzyme (MEME) synthesis of 2,7-anhydro-sialic acid derivatives
por: Monestier, Marie, et al.
Publicado: (2017)

Potential roles of 1,5-anhydro-d-fructose in modulating gut microbiome in mice
por: Ito, Takashi, et al.
Publicado: (2021)

Excessive daytime napping independently associated with decreased insulin sensitivity in cross-sectional study – Hyogo Sleep Cardio-Autonomic Atherosclerosis cohort study
por: Kakutani-Hatayama, Miki, et al.
Publicado: (2023)

Poly[[μ-1,4-anhydroerythritolato-di-μ-aqua-sodium(I)] monohydrate]
por: Kerscher, Tobias, et al.
Publicado: (2008)

Expedient synthesis of 1,6-anhydro-α-D-galactofuranose, a useful intermediate for glycobiological tools
por: Baldoni, Luciana, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_18b56ucjiiosst51joglbrcocn